| 1 |
Arif H, Zahid S, Kaura A. Persistent lactic acidosis: thinking outside the box. Cureus. 2018; 10(5): e2561.
|
| 2 |
Kraut JA, Madias NE. Lactic acidosis. N Engl J Med. 2014; 371(24): 2309-19.
doi: 10.1056/NEJMra1309483
|
| 3 |
Gardner AJ, Griffiths J. A case of type B lactic acidosis as a complication of chronic myelomonocytic leukaemia: a case report and review of the literature. J Med Case Rep. 2015; 9(1): 16.
|
| 4 |
Masood U, Sharma A, Nijjar S, Sitaraman K. B-cell lymphoma, thiamine deficiency, and lactic acidosis. Proc (Bayl Univ Med Cent). 2017; 30(1): 69-70.
pmid: 28127139
|
| 5 |
Elhomsy GC, Eranki V, Albert SG, Fesler MJ, Parker SM, Michael AG, et al. “Hyper-warburgism,” a cause of asymptomatic hypoglycemia with lactic acidosis in a patient with non-Hodgkin’s lymphoma. J Clin Endocrinol Metab. 2012; 97(12): 4311-6.
doi: 10.1210/jc.2012-2327
|
| 6 |
Schuh AM, Leger KJ, Summers C, Uspal NG. Lactic acidosis in a critically ill patient: not always sepsis. Pediatr Emerg Care. 2018 ;34(9): e165-e167.
|
| 7 |
Makino H, Noda K, Inagaki Y, Horie H, Osegawa M, Kanatsuka A, et al. Lactic acidosis and hypoglycemia associated with acute leukemia. Jpn J Med. 1985; 24(3):257-62.
pmid: 3865004
|
| 8 |
Morel S, Leahy J, Fournier M, Lamarche B, Garofalo C, Grimard G, et al. Lipid and lipoprotein abnormalities in acute lymphoblastic leukemia survivors. J Lipid Res. 2017; 58(5): 982-93.
doi: 10.1194/jlr.M072207
pmid: 28274961
|
| 9 |
Naik PP, Ghadge MS, Raste AS. Lipid profile in leukemia and Hodgkin’s disease. Indian J Clin Biochem. 2006; 21(2): 100-2.
doi: 10.1007/BF02912921
|
| 10 |
Toplak H, Ludvik B, Lechleitner M, Dieplinger H, Föger B, Paulweber B, et al. Austrian lipid consensus on the management of metabolic lipid disorders to prevent vascular complications: a joint position statement issued by eight medical societies. 2016 update. Wien Klin Wochenschr. 2016; 128(Suppl 2): S216-S228.
|
)
